Objective. To analyze the long-term results of external beam radiation
therapy in patients under the age of sixty treated with early-stage p
rostate cancer. A comparison is also made between patients with early-
stage, node-negative disease and those with locally advanced node-nega
tive prostate cancer. Methods. In this retrospective study, 54 patient
s who were treated with external beam radiation, when under the age of
sixty with Stanford stage T1a and T1b (equivalent to urologic stage B
1), are compared to 75 patients with similar staged disease who were s
ixty to seventy years old at time of treatment. In addition, 1 7 men w
ho underwent open lymph node dissection with Stanford stage T1a and T1
b NOMO (equivalent to urologic stage B1, pathologic node negative) wer
e compared to 30 patients with Stanford stage T3NOMO (equivalent to ur
ologic stage C, pathologic node negative) prostatic carcinoma. Results
. Patients under the age of sixty with clinically staged early prostat
e cancer exhibited a similar rate of local and metastatic control when
compared to men treated when sixty to seventy years of age. Overall s
urvival was not different than the expected survival in both groups. I
n patients with laparotomy-proven node-negative prostate cancer, those
with locally advanced tumors had a poorer rate of local control, dise
ase-specific survival, freedom from relapse, and survival when compare
d to patients with early-stage disease. Conclusions. These results sug
gest that men under sixty years old are candidates for radiotherapy, a
nd these results are comparable to those attained with prostatectomy.
Treatment approaches for controlling bulky local disease in patients w
ithout lymph node metastases have a potential to improve local control
that may have an impact on survival.